So-Young International Inc. manages a digital platform specializing in medical aesthetics and elective healthcare services, serving customers in the People's Republic of ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $-0.52 · Revenue $527.54M · 1 analysts
Est. EPS $-0.42 · Revenue $572.68M · 1 analysts
Est. EPS $-2.38 · Revenue $2.07B · 1 analysts
Est. EPS $-0.58 · Revenue $2.78B · 1 analysts
EPS ¥-0.17 · Revenue ¥503.80M
EPS ¥-0.37 · Revenue ¥430.16M
EPS ¥-1.78 · Revenue ¥1.48B
EPS ¥-0.49 · Revenue ¥386.67M
EPS ¥-0.28 · Revenue ¥378.75M
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $1.5B | +1.0% | +17.1% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-235.7M | +60.0% | +53.7% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +47.8% | -22.1% | +5.0% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -17.5% | +58.9% | +35.4% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -15.9% | +60.4% | +60.5% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $-302.0M | -242.5% | +100.0% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | -20.4% | -239.0% | +100.0% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 19.3% | +47.9% | +1.7% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.89x | -30.8% | -6.7% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $2.7B | -3.1% | +0.9% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -1.78 vs -1.86 | +4.0% | -0.17 vs -0.60 | +71.5% |
| Revenue Surprise | $1.5B vs $1.5B | -1.1% | $503.8M vs $477.9M | +5.4% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Jan 1, 2029 | Wang Bei | director, officer: CMO | Option (right to buy) | — | 3,211 | $0.01 |
| Jan 1, 2029 | Li Gefei | director, officer: COO | Option (right to buy) | — | 8,018 | $0.01 |
| Jun 15, 2026 | Li Gefei | director, officer: COO | Class A ordinary share, par value US$0.01 | A | 23,076 | $0.01 |
| Jun 15, 2026 | Li Gefei | director, officer: COO | Option (right to buy) | D | 21,153 | $0.01 |
| Jun 10, 2026 | Wang Bei | director, officer: CMO | Class A ordinary share, par value US$0.01 | A | 30,260 | $0.01 |
Operator: Ladies and gentlemen, thank you for standing by for So-Young's First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference call is being recorded. I would now like to turn the meeting over to your host for today's call, Ms. Mona Qiao. Please proceed, Mona. Mona Qiao: Thank you, operator, and thank you, everyone, for joining So-Young's First Quarter 2026 Earnings Conference Call. Joining me today on the call is Mr. Xing Jin, Founder, Chairman and CEO; and Ms. Zhang Sha, VP of Finance. Before we begin, please refer to the safe harbor statements in our earnings release, which applies today's call as we will be making forward-looking statements. Please also note that we will discuss non-GAAP measures today, which are more thoroughly explained and reconciled to the most comparable measures reported under GAAP in our earnings release on our Investor Relations website and filings with SEC. Please also note, all figures mentioned in this call are in RMB. And this time, I'd like to turn the call over to Mr. Xing Jin. Xing Jin: [Foreign Language] Mona Qiao: [Interpreted] Hello, everyone, and welcome to today's earnings call. Xing Jin: [Foreign Language] Mona Qiao: [Interpreted] entering 2026, China's medical aesthetic industry continues to evolve with demand becoming more [ retained ] and supply continue to grow. Large-scale operational capabilities and a uniform delivery framework have become the key mode for top players to achieve high-quality growth. We capitalized on this by expanding our aesthetic center business and advancing our dual engine of scale and efficiency initiative. As a result, we achieved robust performance. In Q1, total revenue reached RMB 433 million, up around 46% year-over-year. Revenue from our aesthetic center business reached RMB 282 million, up around 186% year-over-year. Xing Jin: [Foreign Language] Mona Qiao: [Interpreted] now let's take a closer look at our recent progress across a few core areas. Xing Jin: [Foreign Language] Mona Qiao: [Interpreted] The So-Young Clinic continued to lead So-Young's light medical aesthetics chain market, ranking #1 by center count treatment volume and user base. Our operational efficiency and profitability also continued to improve. Xing Jin: [Foreign Language] Mona Qiao: [Interpreted] In terms of center footprint, as of today, So-Young Clinic has expanded into 17 cities with 59 centers in total. That is a net add of 10 centers compared to year-end 2025. On treatment volume in Q1, verified treatment visit exceeded 148,000, up 172% year-over-year. The number of verified treatment performed was over 325,000, up 164% year-over-year. Our active user base expanded further reaching over [ 310,000 ] by March end. Within that, the number of Level 3 and above core members exceeded 63,000. Core members maintained a high quarterly repurchase rate as we further our [ LTV, ] driven by excellent user experience and [ positive ]. The proportion of new …
| Name | Title | Gender | Year Born | Status |
|---|---|---|---|---|
Xing Jin | Co-Founder, Chief Executive Officer & Chairman | Male | 1980 | Active |
Nan Shen | Chief Financial Officer & Director | Female | 1984 | Active |
Gefei Li | Chief Operating Officer & Director | Female | 1995 | Active |
Mona Qiao | Investor Relations Officer | Female | — | Active |
Bei Wang | Chief Marketing Officer & Director | Female | 1986 | Active |
Christian Arnell | Investor Relations Officer | Male | — | Active |
Vivian | Investor Relations Officer | Female | — | Active |
Tao Yu | Co-Founder & Consultant | Male | 1979 | Active |
BEIJING, Aug. 4, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that the board of directors of the Company (the "Board") has appointed Ms. Nan Shen as the Company's Chief Financial Officer, effective August 3, 2026.
Shares of Here Group, Zepp Health, Burning Rock Biotech and So-Young International all posted meteoric gains last year, but have given most of that back in 2026
I lower my rating for So-Young International from 'Buy' to 'Hold' after analyzing its mixed 1Q2026 performance. 1Q2026 revenues surged 46% YoY, as the pivot towards offline aesthetic clinics paid off. But SY's net losses widened year-on-year in the first quarter due to lower contributions from high-margin online operations and costs relating to footprint expansion.
So-Young International Inc. (SY) Q1 2026 Earnings Call Transcript
So-Young International NASDAQ: SY reported sharply higher first-quarter 2026 revenue, driven by rapid growth in its branded aesthetic center business, while management said the company is continuing to expand its clinic footprint and invest in standardized medical delivery.
